No Data
Kyland Technology (300353.SZ): Plans to launch the 2025 Stocks Options incentive program.
On February 19, Gelonghui丨Kyland Technology (300353.SZ) announced the 2025 stock options incentive plan (draft), which proposes to grant a total of 6.6667 million stock options to the incentive targets, accounting for 1.08% of the company's total share capital of 614.8929 million shares as of the announcement of this incentive plan draft; among them, the initial grant of 5.3333 million shares accounts for 0.87% of the company's total share capital of 614.8929 million shares as of the announcement of this incentive plan draft, and 1.3333 million shares are reserved for grant, accounting for the same proportion.
Kyland Technology (300353.SZ): The net income for the year 2024 is expected to decrease by 82.71% to 88.47%.
On January 22, Gloroinvest reported that Kyland Technology (300353.SZ) announced the performance forecast for 2024, with a net income attributable to shareholders of the listed company expected to be between 30 million yuan and 45 million yuan, representing a year-on-year decline of 82.71% to 88.47%; the net income attributable to shareholders of the listed company, after deducting non-recurring gains and losses, is expected to be between 8 million yuan and 12 million yuan, an increase of 107.38% to 111.07% compared to the same period last year. The company’s long-term strategic layout in industrial operating systems and industrial Software has shown results, significantly improving the quality of the company's earnings. The company is involved in Semiconductors.
Dongtu Technology: 2024 performance forecast
Kyland Technology Co., Ltd.'s (SZSE:300353) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Kyland Technology (300353.SZ): Plans to transfer patent rights to a joint venture.
On December 26, Gelonghui reported that Kyland Technology (300353.SZ) announced that the company, together with its affiliated company Peking Neuron Network Technology Co., Ltd. (referred to as "Peking Neuron"), has jointly developed and holds two invention patents, mainly applied in AUTBUS bus chip technology. To optimize the Business layout and further focus on the development of the company's main core business, while fully leveraging the economic value and business potential of the aforementioned patents, the company intends to sign a "Technology Transfer (Patent Rights) Agreement" with Peking Neuron to transfer the aforementioned two invention patents to Peking Neuron for a transfer price of 17.5 million yuan.
While Shareholders of Kyland Technology (SZSE:300353) Are in the Black Over 3 Years, Those Who Bought a Week Ago Aren't so Fortunate